Immediate Treatment of Catatonia
The immediate treatment for a patient presenting with catatonia is intravenous lorazepam at a dose of 1-2 mg, which should be administered as soon as catatonia is recognized. 1, 2, 3
Initial Assessment and Management
When a patient presents with catatonia, characterized by symptoms such as stupor, catalepsy, waxy flexibility, mutism, negativism, posturing, and stereotypies, follow this algorithm:
Rule out medical causes - Check for underlying medical conditions including:
- Infections
- Metabolic disturbances
- Neurological conditions
- Medication effects
- Autoimmune disorders 1
Administer benzodiazepines immediately:
Alternative benzodiazepines if lorazepam unavailable:
Treatment Response Evaluation
After initial benzodiazepine administration:
- If good response (≥50% symptom reduction): Continue benzodiazepine treatment with scheduled doses
- If partial response: Increase benzodiazepine dose
- If poor response (≤50% symptom improvement after 3-4 days of adequate benzodiazepine trial): Proceed to electroconvulsive therapy (ECT) 1, 4
Second-Line Treatment: Electroconvulsive Therapy (ECT)
ECT should be initiated promptly when:
- Benzodiazepines fail to produce adequate response
- Patient has severe or life-threatening catatonia
- Catatonia is associated with neuroleptic malignant syndrome 1
ECT administration requires:
- Second opinion from a psychiatrist knowledgeable about ECT
- Anesthesia administered by qualified personnel
- Close monitoring for cognitive side effects 1
Special Considerations
- Avoid antipsychotics initially, especially first-generation agents, as they may worsen catatonia or precipitate neuroleptic malignant syndrome
- Monitor vital signs closely as catatonia can be associated with autonomic instability
- Provide supportive care including hydration, nutrition, and thromboprophylaxis
- For patients with known history of catatonia, clozapine may be considered if conventional treatments fail 7
Emerging Treatments
Research suggests sodium oxybate (a GABA-B receptor agonist) may be effective for lorazepam-resistant catatonia, though this remains investigational 4.
Monitoring and Complications
Monitor for potential complications of untreated catatonia:
- Renal failure
- Rhabdomyolysis
- Pneumonia
- Venous thromboembolism
- Contractures 4
The mortality rate of untreated catatonia can reach 10%, emphasizing the importance of prompt recognition and treatment 2, 4.